Detecting Prodigiosin molecular mechanism pathway in Breast Cancer through an integrated systems biology approach

Short Communication

Shaimaa Ahmed Abdel-mougood


 Prodigiosin the red pigment extracted from Serratia marc¬esens and other species, was known as the miracles of bloody bread in the medieval age. it is a “prodigious” com¬pound with high medical and industrial significance. it has antibacterial, antiprotozoal, algicidal, antimalarial, antican¬cer, and immunosuppressive properties it also used indus¬trially as a pigment. Breast cancer (BC) is a heterogeneous disease that considered the most common malignancy in women in several countries. It is classified into several sub-types, each one involving a different gene set controlling for diverse processes. The identification of cancer sub-type depends on the expression of the estrogen receptor (ER), progesterone receptor (PR), cytokeratin (CK) protein and epi¬dermal growth factor receptor 2 (ERBB2). Previous studies have shown that prodigiosin induced significant apoptosis in a broad range of cancer cell lines selectively and effectively target cancer but not healthy cells. Importantly, it is less toxic than other anticancer drugs and its pro-apoptotic effect irre¬spective of p53 status and multidrug resistance, rendering prodigiosin a promising anticancer drug. Through Integrat¬ed Systems Biology tools the aim of this study is to explore possible molecular mechanism pathway of prodigiosin and detect gene signature involved in its therapeutic response.

Relevant Publications in Archives in Food and Nutrition